AbbVie, Inc.
(NYSE : ABBV)

( )
ABBV After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Loading ABBV News...
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
0.18%123.730.7%$674.17m
PFEPfizer Inc.
0.04%33.871.1%$612.35m
BMYBristol-Myers Squibb Company
3.52%55.661.4%$482.79m
MRKMerck & Co., Inc.
-0.21%62.570.6%$479.75m
LLYEli Lilly and Company
0.47%81.340.9%$341.79m
ABBVAbbVie, Inc.
1.55%66.052.0%$337.18m
NVSNovartis AG Sponsored ADR
1.00%77.110.2%$164.81m
GSKGlaxoSmithKline plc Sponsored ADR
0.22%40.770.2%$127.53m
AZNAstraZeneca PLC Sponsored ADR
0.90%30.861.3%$105.75m
NVONovo Nordisk A/S Sponsored ADR Class B
3.83%38.790.1%$97.37m
SNYSanofi Sponsored ADR
0.93%46.850.2%$65.53m
AKTXAkari Therapeutics Plc Sponsored ADR
-8.87%15.000.1%$30.41m
LCILannett Company, Inc.
-2.45%25.9039.1%$19.58m
SCMPSucampo Pharmaceuticals, Inc. Class A
2.02%10.1015.7%$6.86m
EPIXESSA Pharma Inc
0.00%2.090.0%$0.01m

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company. It engages in the discovery, development, manufacture and sale of a broad line of proprietary pharmaceutical products. The company focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.